Journal of Istanbul Faculty of Medicine

SUBMITINFORMATION
EnglishTürkçe

Research Article


DOI :10.26650/IUITFD.2019.0102   IUP :10.26650/IUITFD.2019.0102    Full Text (PDF)

COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY

Gürcan Türkyılmaz, Gökçe Naz Küçükbaş, Emircan Ertürk, Şebnem Türkyılmaz, Onur Karaaslan, Hanım Güler Şahin

Objective: To evaluate folate and B12 levels in fetuses who had been diagnosed with neural tube defects (NTDs) and healthy fetuses in Van Yüzüncü Yıl University and Van State Education and Research hospitals between March-August 2019. Material and Method: Thirty-eight pregnant women who had been diagnosed with fetuses with NTDs prenatally, and 40 healthy controls were recruited. The chi-square test and Mann-Whitney U test were employed to compare variables. Results: None of the women had taken folic acid preconceptionally in the NTD group. However, 4 (10%) women had taken folic acid supplementation in the preconception period in the control group, and this was significantly different among the groups (p=0.04). The women who had taken folic acid in the first trimester of pregnancy were 9 (23.6%) and 32 (80%) in cases and controls, respectively, and it was significantly different (p=0.01). The mean B12 level was 248.7±65.4ng/ml in cases and 239.3±27.5 ng/ml in controls, and there was no significance between the groups (p=0.78). The mean folate level was 9.6±4.8 ng/ml in cases and 9.8±3.9 ng/ ml in controls, and it was similar between the groups (p=0.62). Conclusion: We did not show difference in folate and B12 levels. However, folic acid intake in preconception or in the first trimester of pregnancy was significantly higher in women who have healthy babies compared to the NTD group. 

Keywords: Folate, neural tube defect, prenatal, supplementation, vitamin B12
DOI :10.26650/IUITFD.2019.0102   IUP :10.26650/IUITFD.2019.0102    Full Text (PDF)

PRENATAL FETAL NÖRAL TÜP DEFEKTİ TANISI KONULAN ANNELERDE SERUM B12 VE FOLAT DÜZEYLERİNİN KARŞILAŞTIRILMASI: VAKA-KONTROL ÇALIŞMASI

Gürcan Türkyılmaz, Gökçe Naz Küçükbaş, Emircan Ertürk, Şebnem Türkyılmaz, Onur Karaaslan, Hanım Güler Şahin

Amaç: Van Yüzüncü Yıl Üniversitesi ve Van Eğitim ve Araştırma Hastanesi’nde NTD tanısı koyulan ve sağlıklı fetüsü olan gebelerin B12 ve folat düzeyini karşılaştırdık. Gereç ve Yöntem: NTD tanısı koyulan 38 hasta ve 40 kontrol grubu çalışmaya dahil edildi. İstatistiksel analizde ki-kare testi ve Mann-Whitney U testi kullanıldı. Bulgular: NTD grubunda hiçbir hastada prekonsepsiyonel dönemde folik asit kullanımı yoktu ancak kontrol grubunda 4 (%10) hastada prekonsepsiyonel folik asit kullanımı mevcuttu ve bu fark istatistiksel olarak anlamlıydı (p=0,04). NTD grubunda 9 (%23.6), kontrol grubunda 32 (%80) hastada ilk trimesterde folik asit desteği alınmıştı ve bu istatistiksel olarak anlamlıydı (p=0,01). Ortalama B12 seviyesi NTD grubunda 248.7±65.4ng/ml, kontrol grubunda 239.3±27.5 saptandı ve bu fark anlamlı değildi (p=0,78). Ortalama folat seviyesi NTD grubunda 9.6±4.8 ng/ml, kontrol grubunda 9.8±3.9 ng/ml saptandı ve bu fark anlamlı değildi (p=0,62). Sonuç: Her iki grup arasında B12 ve folat seviyeleri farklı değildi ancak, sağlıklı bebeği olan grupta prekonsepsiyonel dönemde ve ilk trimesterde folik asit kullanımı NTD grubuna göre anlamlı olarak daha fazlaydı.

Keywords: Folat, nöral tüp defekti, prenatal, vitamin B12

PDF View

References

  • 1. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999;341(20):1509-19. google scholar
  • 2. Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, Cole DE, et al. Vitamin B12 and the risk of neural tube defects in a folic acid fortfied population. Epidemiology 2007;18(3):362-6. google scholar
  • 3. Greene ND, Stainer P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet 2009;18 (R2):R113-R129. google scholar
  • 4. Czeizel AE, Dudas I. Prevention of the first occurance of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327(26):1832-5. google scholar
  • 5. Au KS, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev 2010;16(1):6-15. google scholar
  • 6. Van Loon K, Besseghir K, Eshkol A. Neural tube defects after infertility treatment: a review. Fertil Steril 1992;58(5):875-84. google scholar
  • 7. Wald NJ, Hackshaw AD, Stone R. Blood folic acid and vitamin B12 in relation to neural tube defects: a case control study. Biol Neonate 1995;67(3):154-9. google scholar
  • 8. Weir DG, Scott JM. Cobalamins: Physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B. eds. Encylopedia of Human Nutrition. San Diego, CA, Academic Press 1999:394-401. google scholar
  • 9. Cech I, Burau KD. Serological differences in folate/vitamin B12 in pregnancies affected by neural tube defects. South Med J 2010;103(5):419-24. google scholar
  • 10. Zhang T, Xin R, Gu X, Wang F, Pei L, Zheng Z, et al. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspirng in a high risk area of China. Public Health Nutr 2009;12(5):680-6. google scholar
  • 11. Mobasheri E, Keshtkar A, Golalipour MJ. Maternal folate and vitamin B12 status and neural tube defects in northern Iran: a case control study. Iran J Pediatr 2010;20(2):167-73. google scholar
  • 12. Aydın H, Arısoy R, Karaman A, Erdogdu E, Cetinkaya A, Demirci O, et al. Evaluation of maternal serum folate, vitamin B12, and homocysteine levels and factor V Leiden, factor 2 g.20212G>A, and MTHRF variations in prenatally diagnosed neural tube defects. Turk J Med Sci 2016;46(2):489-94. google scholar
  • 13. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991;338(8760):131-7. google scholar
  • 14. Tinker SC, Cogswell ME, Devine O, Berry RJ. Folic acid intake among U.S. women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006. Am J Prev Med 2010;38(5):534-42. google scholar
  • 15. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. QJM 1993;86(11):703-8. google scholar
  • 16. Molloy AM, Kirke PN, Troandle JF, Burke H, Sutton M, Mills JL, et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defects prevalance and no folic acid fortification. Pediatrics 2009;123(3):917-23. google scholar
  • 17. Ceyhan ST, Beyan C, Atay V, Yaman H, Alanbay I, Başer I, et al. Serum vitamin B12 and homocysteine levels in pregnant women with neural tube defects. Gynecol Endocrinol 2010;26(8):578-81. google scholar
  • 18. Mills JL, Scott JM, Kirke PN, McPartlin JM, Conley MR, Weir DG, Molloy AM, Lee YJ. Homocysteine and neural tube defects. J Nutr 1996;126(3):756-60. google scholar
  • 19. Yang M, Li W, Wan Z, Du Y. Elevated homocysteine levels in mothers with neural tube defects: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2017;30(17):2051-57. google scholar
  • 20. Van der Put NM, Steegers-eunissen RPM, Frosst P, Trijbels FJ, Eskes TK, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346(8982):1070-1. google scholar
  • 21. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Whitehead AS. The ‘thermolabile’ variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 1999;64(4):1045-55. google scholar
  • 22. Liu J, Qi J, Yu X, Zhu J, Zhang L, Luo X, et al. Investigations of single nucleotide polymorphisms in folate pathway genes in Chinese families with neural tube defect. J Neurol Sci 2014;337(1-2):61-6. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Türkyılmaz, G., Küçükbaş, G.N., Ertürk, E., Türkyılmaz, Ş., Karaaslan, O., & Şahin, H.G. (2020). COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY. Journal of Istanbul Faculty of Medicine, 83(4), 325-329. https://doi.org/10.26650/IUITFD.2019.0102


AMA

Türkyılmaz G, Küçükbaş G N, Ertürk E, Türkyılmaz Ş, Karaaslan O, Şahin H G. COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY. Journal of Istanbul Faculty of Medicine. 2020;83(4):325-329. https://doi.org/10.26650/IUITFD.2019.0102


ABNT

Türkyılmaz, G.; Küçükbaş, G.N.; Ertürk, E.; Türkyılmaz, Ş.; Karaaslan, O.; Şahin, H.G. COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 83, n. 4, p. 325-329, 2020.


Chicago: Author-Date Style

Türkyılmaz, Gürcan, and Gökçe Naz Küçükbaş and Emircan Ertürk and Şebnem Türkyılmaz and Onur Karaaslan and Hanım Güler Şahin. 2020. “COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY.” Journal of Istanbul Faculty of Medicine 83, no. 4: 325-329. https://doi.org/10.26650/IUITFD.2019.0102


Chicago: Humanities Style

Türkyılmaz, Gürcan, and Gökçe Naz Küçükbaş and Emircan Ertürk and Şebnem Türkyılmaz and Onur Karaaslan and Hanım Güler Şahin. “COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY.” Journal of Istanbul Faculty of Medicine 83, no. 4 (Apr. 2024): 325-329. https://doi.org/10.26650/IUITFD.2019.0102


Harvard: Australian Style

Türkyılmaz, G & Küçükbaş, GN & Ertürk, E & Türkyılmaz, Ş & Karaaslan, O & Şahin, HG 2020, 'COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY', Journal of Istanbul Faculty of Medicine, vol. 83, no. 4, pp. 325-329, viewed 26 Apr. 2024, https://doi.org/10.26650/IUITFD.2019.0102


Harvard: Author-Date Style

Türkyılmaz, G. and Küçükbaş, G.N. and Ertürk, E. and Türkyılmaz, Ş. and Karaaslan, O. and Şahin, H.G. (2020) ‘COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY’, Journal of Istanbul Faculty of Medicine, 83(4), pp. 325-329. https://doi.org/10.26650/IUITFD.2019.0102 (26 Apr. 2024).


MLA

Türkyılmaz, Gürcan, and Gökçe Naz Küçükbaş and Emircan Ertürk and Şebnem Türkyılmaz and Onur Karaaslan and Hanım Güler Şahin. “COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY.” Journal of Istanbul Faculty of Medicine, vol. 83, no. 4, 2020, pp. 325-329. [Database Container], https://doi.org/10.26650/IUITFD.2019.0102


Vancouver

Türkyılmaz G, Küçükbaş GN, Ertürk E, Türkyılmaz Ş, Karaaslan O, Şahin HG. COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY. Journal of Istanbul Faculty of Medicine [Internet]. 26 Apr. 2024 [cited 26 Apr. 2024];83(4):325-329. Available from: https://doi.org/10.26650/IUITFD.2019.0102 doi: 10.26650/IUITFD.2019.0102


ISNAD

Türkyılmaz, Gürcan - Küçükbaş, GökçeNaz - Ertürk, Emircan - Türkyılmaz, Şebnem - Karaaslan, Onur - Şahin, HanımGüler. “COMPARISON OF MATERNAL B12 AND FOLATE STATUS IN PRENATALLY DIAGNOSED NEURAL TUBE DEFECTS: A CASE-CONTROL STUDY”. Journal of Istanbul Faculty of Medicine 83/4 (Apr. 2024): 325-329. https://doi.org/10.26650/IUITFD.2019.0102



TIMELINE


Submitted18.12.2019
Accepted09.05.2020
Published Online19.10.2020

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.